News from the:
European Society of Cardiology (ESC) Congress 2014
August 30 - September 03, 2014; Barcelona, Spain
The Cardiology Show
Meeting Highlights at a Glance
- ESC Fewer CRT-Lead-Related Complications With Quadripolar Vs Bipolar Leads: MORE CRT Trial
- ESC WEARIT-II: Wearable Defibrillator Safe, Helps in ICD Decision
- ESC New Revascularization Guidelines Trim Back Bivalirudin, DAPT
- ESC Antihypertensives Up Survival but May Cause Falls in Seniors
- ESC Hypertension up to Six Times More Likely in Obese vs Slim Youth
- ESC Short-Term Amiodarone After AF Ablation Won't Block Late AF
- ESC IMPI: No Immunotherapy Benefit in Tuberculous Pericarditis
- ESC FOCUS: More MI Survivors Adhere to Polypill Than Three Pills
- ESC SYMPLICITY at One Year: Still No BP Benefit vs Controls
- ESC Heart Stop: Subway Stations Among Best AED Sites In Paris
- ESC Iron Therapy Boosts Function, QoL in HF Patients: CONFIRM HF
- ESC Find It, Treat It: 'Lousy' Prognosis for Asymptomatic AF
- ESC TASTE at One Year: No Gains from Thrombectomy in PCI for STEMI
- ESC Beta-Blockers No Use in HF Patients With Atrial Fibrillation
- ESC PARADIGM-HF: Some Say, 'A New Day in Heart Failure'
- ESC BIOSCIENCE: DES With Biodegradable Polymer Matches Comparator
- ESC Rosuvastatin Reduces Plaque Volume in STEMI Patients
- ESC Mechanical Valves in Pregnancy: Scant Progress, Big Risks
- ESC Brilinta Prehospital: No Reperfusion Boost, Less Thrombosis
- ESC X-VERT: Rivaroxaban a Warfarin Alternative in AF Cardioversion
- ESC FAME-2 and FAMOUS: FFR Impressive in Stable CAD and ACS
- ESC More Proof: Renal Denervation Success Needs Total Ablation
- ESC Dramatic Drop in MACE With Complete vs Culprit P-PCI
- ESC Can Beta-Blockers Be Stopped Post-AMI With Preserved LVEF?
- ESC SIGNIFY: No Ivabradine Clinical Outcomes Gain in Stable CAD
- ESC Huge Decreases in LDL Cholesterol With Alirocumab: ODYSSEY
- ESC Colchicine 'Useless' for Postop Pericardial Effusion: POPE-2
- ESC Darapladib No Benefit in ACS Patients: SOLID-TIMI 52
- ESC 15-Year Data Show Better Survival in Elderly AMI Patients
- ESC Highly Sensitive cTnT Safely Rules Out MI in One Hour
- ESC New-Generation DES Match BMS Stent Safety Beyond One Year: SCAAR
- ESC NECTAR-HF Vagal-Nerve Stimulation Study Misses End Points
- ESC COPPS-2: Colchicine Stops Postop Pericarditis, Troubles Gut
- ESC PARADIGM-HF: New Drug Class Outclasses ACE-I in Chronic HF
- ESC What's Going to Be Hot at ESC Congress 2014
Perspectives from ESC
- How to Manage Muscle Pain in Patients on Statins
- Faster, Cheaper, Clinical Trials: Are We There Yet?
- Electrophysiology Data From ESC Explained
- NOAC Update on Dosing and Transitioning
- Vagal Nerve Stimulation in HF: Mixed Findings at ESC
- Lipids Lowdown From ESC: PCSK9 Inhibitors and LDL-C Goals
- Antithrombotics in ACS and TAVR
- ATLANTIC: Prehospital vs Cath Lab Ticagrelor in Primary PCI
- New and Improved: ESC Guidelines for Pulmonary Embolism
- A Rapid-Fire Review of Four Big Trials From ESC 2014
- PARADIGM-HF: Is It Applicable to US Patients?
- Will CvLPRIT Change US Primary PCI Guidelines?
Bloggers From the Floor
- 'Just-Because' Use of Beta-blockers Questioned at ESC 2014
- Finding the Optimal Approach to Ablation of Persistent AF
- Seeing the Future of Batteryless Cardiac Devices
- Dedicated AF Clinics: There Is No 'I' in TEAM
- 10 Reasons to Like PARADIGM-HF and Four That Warrant Pause
- A 43-Year-Old With a Calcium Score of 347: What to Do?
- Not All CHA 2DS 2-VASc 1s Are Created Equal: No Kidding
- CvLPRIT: Validating the Interventionalist's Will to Indulge?
- TAVI: What's new? LOTS!
- CONFIRM-HF: Changing the Who's Who of IV Iron Therapy